Home > Boards > US Listed > Biotechs > Vascular Biogenics Ltd. (VBLT)

Next step is ovarian . They must succeed.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Oren1976 Member Profile
 
Followed By 1
Posts 375
Boards Moderated 0
Alias Born 12/04/16
160x600 placeholder
VBL Therapeutics Presents MOSPD2 Bi-Specific Antibody Activity and Potential Survival Benefit for Solid Tumors in Late Breaki... GlobeNewswire Inc. - 6/22/2020 8:00:10 AM
VBL Presents New Data on the Potential of its Novel anti-MOSPD2 Monoclonal Antibodies for Rheumatoid Arthritis at the EULAR 2... GlobeNewswire Inc. - 6/4/2020 7:00:10 AM
VBL Therapeutics to Present New Data on Its MOSPD2 Bispecific Antibody Program for Solid Tumors in Late Breaking Research Ses... GlobeNewswire Inc. - 5/18/2020 7:00:10 AM
VBL Therapeutics Announces First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/14/2020 7:00:10 AM
VBL Presents New Data on MOSPD2 Antibodies as Potential Treatment for NASH and Colitis at DDW GlobeNewswire Inc. - 5/6/2020 7:00:10 AM
VBL First-in-class MOSPD2 Antibodies Show Potential for Treatment for CNS Inflammation GlobeNewswire Inc. - 5/4/2020 7:00:10 AM
VBL Therapeutics to Report Fourth Quarter 2019 Financial Results on March 19 GlobeNewswire Inc. - 3/2/2020 8:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/21/2020 2:52:42 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/30/2019 4:16:02 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/23/2019 4:16:33 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/14/2019 7:01:47 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/1/2019 4:16:15 PM
VBL Therapeutics to Report Third Quarter 2019 Financial Results on November 14 GlobeNewswire Inc. - 10/31/2019 8:00:05 AM
Amended Report of Foreign Issuer (6-k/a) Edgar (US Regulatory) - 8/29/2019 5:26:17 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/13/2019 7:01:03 AM
VBL Therapeutics to Report Second Quarter 2019 Financial Results on August 13 GlobeNewswire Inc. - 8/5/2019 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/1/2019 11:17:55 AM
VBL Therapeutics Announces Modiin Production Facility Received a GMP Compliance Certificate Following EU QP Audit GlobeNewswire Inc. - 7/22/2019 8:00:00 AM
Oren1976   Thursday, 11/15/18 08:32:35 AM
Re: MF82 post# 1969
Post # of 2003 
Next step is ovarian . They must succeed. Fever is the key. Unfortunately they don't push to fever like injecting directly to tumor and they still reduce fever using anti fever drugs. The only hope is the good ph2 result in ovarian

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist